(Q38103288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

main subject

hereditary angioedema

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Andrea Zanichelli

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Marta Mansi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Giulia Periti

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

477-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

Clinical practice. Hereditary angioedema

29 February 2020

cites work

1 reference

Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates.

21 January 2018

1 reference

Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor

21 January 2018

1 reference

Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions

21 January 2018

1 reference

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

21 January 2018

1 reference

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

21 January 2018

1 reference

Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.

21 January 2018

1 reference

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

21 January 2018

1 reference

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 January 2018

1 reference

C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress

21 January 2018

1 reference

C1 inhibitor and hereditary angioneurotic edema

21 January 2018

1 reference

The pathophysiology of hereditary angioedema

21 January 2018

1 reference

Bradykinin-mediated angioedema

21 January 2018

1 reference

Plasma bradykinin in angio-oedema.

21 January 2018

1 reference

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

21 January 2018

1 reference

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

21 January 2018

1 reference

Hereditary angioedema: a broad review for clinicians

21 January 2018

1 reference

Sudden upper airway obstruction in patients with hereditary angioedema

21 January 2018

1 reference

HAE international home therapy consensus document.

21 January 2018

1 reference

Angioedema due to C1 inhibitor deficiency in 2010.

21 January 2018

1 reference

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

21 January 2018

1 reference

Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema

21 January 2018

1 reference

The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey.

21 January 2018

1 reference

Hereditary angioedema and pregnancy

21 January 2018

1 reference

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

21 January 2018

1 reference

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study

21 January 2018

1 reference

Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema

21 January 2018

1 reference

Safety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy.

21 January 2018

1 reference

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema

21 January 2018

1 reference

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.

21 January 2018

1 reference

Pathogen safety of human C1 esterase inhibitor concentrate

21 January 2018

1 reference

Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database

21 January 2018

1 reference

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema

21 January 2018

1 reference

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

21 January 2018

1 reference

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant

21 January 2018

1 reference

Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies

21 January 2018

1 reference

When is prophylaxis for hereditary angioedema necessary?

21 January 2018

1 reference

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities

21 January 2018

1 reference

Methyltestosterone Therapy in Hereditary Angioedema

21 January 2018

1 reference

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

21 January 2018

1 reference

Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients

21 January 2018

1 reference

Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience

21 January 2018

1 reference

Appraisal of danazol prophylaxis for hereditary angioedema

21 January 2018

1 reference

Management of upper airway edema caused by hereditary angioedema

21 January 2018

1 reference

C1 inhibitor deficiency: consensus document

21 January 2018

1 reference

Management of hereditary angioedema in pediatric patients.

21 January 2018

1 reference

Tranexamic acid: a review of its use in surgery and other indications

21 January 2018

1 reference

The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database

21 January 2018

1 reference

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

21 January 2018

1 reference

Prophylactic therapy in children with hereditary angioedema.

21 January 2018

1 reference

Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency

21 January 2018

1 reference

Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study

21 January 2018

1 reference

Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema

21 January 2018

1 reference

The bradykinin-forming cascade and its role in hereditary angioedema

21 January 2018

1 reference

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

21 January 2018

1 reference

C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.13.22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23634741%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference